Bioengineering & Translational Medicine

Papers
(The H4-Index of Bioengineering & Translational Medicine is 30. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Hydrogels in the clinic237
Nanoparticles in the clinic: An update post COVID‐19 vaccines169
Cytosolic delivery of nucleic acids: The case of ionizable lipid nanoparticles134
Chitosan nanofiber biocomposites for potential wound healing applications: Antioxidant activity with synergic antibacterial effect106
Viral vector‐based gene therapies in the clinic93
A review of biomimetic scaffolds for bone regeneration: Toward a cell‐free strategy68
Cell therapies in the clinic65
Implant‐bone‐interface: Reviewing the impact of titanium surface modifications on osteogenic processes in vitro and in vivo62
An engineered probiotic secreting Sj16 ameliorates colitis via Ruminococcaceae/butyrate/retinoic acid axis44
Doxorubicin‐loaded nanoparticle coated with endothelial cells‐derived exosomes for immunogenic chemotherapy of glioblastoma44
Temporal profiling of cytokines in passively expressed sweat for detection of infection using wearable device43
Dendrimer size effects on the selective brain tumor targeting in orthotopic tumor models upon systemic administration41
(Nano)platforms in bladder cancer therapy: Challenges and opportunities40
Therapeutic potential of extracellular vesicle‐associated long noncoding RNA40
Advanced strategies to thwart foreign body response to implantable devices37
The effect of size, charge, and peptide ligand length on kidney targeting by small, organic nanoparticles36
Alzheimer's and Parkinson's disease therapies in the clinic36
Inhalable bacteriophage powders: Glass transition temperature and bioactivity stabilization35
Oxidative pentose phosphate pathway and glucose anaplerosis support maintenance of mitochondrial NADPH pool under mitochondrial oxidative stress34
Nanoparticles containing constrained phospholipids deliver mRNA to liver immune cells in vivo without targeting ligands33
Fourth‐generation glucose sensors composed of copper nanostructures for diabetes management: A critical review32
In situ forming microporous gelatin methacryloyl hydrogel scaffolds from thermostable microgels for tissue engineering32
Nanocomposite hydrogels for biomedical applications32
Chitosan‐based nanoscale systems for doxorubicin delivery: Exploring biomedical application in cancer therapy32
Cell loaded hydrogel containing Ag‐doped bioactive glass–ceramic nanoparticles as skin substitute: Antibacterial properties, immune response, and scarless cutaneous wound regeneration31
Intradermal delivery of receptor‐binding domain of SARS‐CoV‐2 spike protein with dissolvable microneedles to induce humoral and cellular responses in mice31
Clinical translation of choline and geranic acid deep eutectic solvent31
Magnetic microgels and nanogels: Physical mechanisms and biomedical applications31
A review of biomarkers in the context of type 1 diabetes: Biological sensing for enhanced glucose control31
RNA therapeutics in the clinic30
0.033997058868408